Search Results - Ian L. Megson

Refine Results
  1. 1
    Recent developments in nitric oxide donor drugs

    Recent developments in nitric oxide donor drugs by Mark R. Miller, Ian L. Megson

    Published 2007
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro‐inflammatory and anti‐inflammatory agents: key role for TNF‐α

    Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro‐inflammatory and anti‐inflammatory agents: key role for TNF‐α by Sylwia Michlewska, Ian Dransfield, Ian L. Megson, Adriano G. Rossi

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis

    Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis by Emma Taylor, Ian L. Megson, Christopher Haslett, A G Rossi

    Published 2003
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Synthesis of novel vanillin derivatives: novel multi-targeted scaffold ligands against Alzheimer's disease

    Synthesis of novel vanillin derivatives: novel multi-targeted scaffold ligands against Alzheimer's disease by Matteo Scipioni, Graeme Kay, Ian L. Megson, Paul Kong Thoo Lin

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Mechanisms of Resolution of Inflammation

    Mechanisms of Resolution of Inflammation by Benjamin H. Maskrey, Ian L. Megson, Phillip D. Whitfield, Adriano G. Rossi

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Iron‐sulphur cluster nitrosyls, a novel class of nitric oxide generator: mechanism of vasodilator action on rat isolated tail artery

    Iron‐sulphur cluster nitrosyls, a novel class of nitric oxide generator: mechanism of vasodilator action on rat isolated tail artery by Frederick W. Flitney, Ian L. Megson, David E. Flitney, A. R. BUTLER

    Published 1992
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activity

    A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activity by Catriona M Turnbull, Danny McClure, Adriano G. Rossi, Ian L. Megson

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Bioactive polyphenols and cardiovascular disease: chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response?

    Bioactive polyphenols and cardiovascular disease: chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response? by Katarzyna Goszcz, Garry G. Duthie, Derek Stewart, Stephen J Leslie, Ian L. Megson

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Bioavailable Concentrations of Delphinidin and Its Metabolite, Gallic Acid, Induce Antioxidant Protection Associated with Increased Intracellular Glutathione in Cultured Endothelial Cells

    Bioavailable Concentrations of Delphinidin and Its Metabolite, Gallic Acid, Induce Antioxidant Protection Associated with Increased Intracellular Glutathione in Cultured Endothelia... by Katarzyna Goszcz, Sherine J. Deakin, Garry G. Duthie, Derek Stewart, Ian L. Megson

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease

    Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease by Denise Burtenshaw, Michael Kitching, Eileen M. Redmond, Ian L. Megson, Paul A. Cahill

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Antioxidants in Cardiovascular Therapy: Panacea or False Hope?

    Antioxidants in Cardiovascular Therapy: Panacea or False Hope? by Katarzyna Goszcz, Sherine J. Deakin, Garry G. Duthie, Derek Stewart, Stephen J Leslie, Ian L. Megson

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes

    Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes by Kyle R. Gibson, Tim J Winterburn, Fiona Barrett, Sushma Sharma, Sandra MacRury, Ian L. Megson

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    NiO and Co3O4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis

    NiO and Co3O4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis by W.-S. Cho, Rodger Duffin, Mark Bradley, Ian L. Megson, William MacNee, Sarah Howie, Kenneth Donaldson

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Oral Vitamin C Reduces Arterial Stiffness and Platelet Aggregation in Humans

    Oral Vitamin C Reduces Arterial Stiffness and Platelet Aggregation in Humans by Ian B. Wilkinson, Ian L. Megson, Helen MacCallum, Naoki Sogo, John R. Cockcroft, David J. Webb

    Published 1999
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    The 2011 Survey on Hypertensive Disorders of Pregnancy (HDP) in China: Prevalence, Risk Factors, Complications, Pregnancy and Perinatal Outcomes

    The 2011 Survey on Hypertensive Disorders of Pregnancy (HDP) in China: Prevalence, Risk Factors, Complications, Pregnancy and Perinatal Outcomes by Chun Ye, Yan Ruan, Liying Zou, Guanghui Li, Changdong Li, Yi Chen, Chaoxia Jia, Ian L. Megson, Jun Wei, Weiyuan Zhang

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Exosomal Composition, Biogenesis and Profiling Using Point-of-Care Diagnostics—Implications for Cardiovascular Disease

    Exosomal Composition, Biogenesis and Profiling Using Point-of-Care Diagnostics—Implications for Cardiovascular Disease by Denise Burtenshaw, Brian Regan, K. Owen, D. A. Collins, David McEneaney, Ian L. Megson, Eileen M. Redmond, Paul A. Cahill

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    2‐arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors

    2‐arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors by Oliver P. Keown, Timothy J. Winterburn, Cherry L. Wainwright, Sandra MacRury, Ilene L Neilson, Fiona Barrett, Stephen J Leslie, Ian L. Megson

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Col4a1 mutation in mice causes defects in vascular function and low blood pressure associated with reduced red blood cell volume

    Col4a1 mutation in mice causes defects in vascular function and low blood pressure associated with reduced red blood cell volume by Tom Van Agtmael, Matthew A. Bailey, Ursula Schlötzer‐Schrehardt, Eilidh Craigie, Ian J. Jackson, David G. Brownstein, Ian L. Megson, John J. Mullins

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System

    Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System by Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, Adriano G. Rossi, Nicole Brace, Paul A. Cahill, Sandra MacRury, Jun Wei, Ian L. Megson

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages

    A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages by Catriona M Turnbull, Paolo Marcarino, Tara A. Sheldrake, Loretta Lazzarato, Clara Cena, Roberta Fruttero, Alberto Gasco, Sarah Fox, Ian L. Megson, Adriano G. Rossi

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: